• OPEN AN ACCOUNT
Indian Indices
Nifty
25,149.85 -205.40
(-0.81%)
Sensex
82,500.47 -689.81
( -0.83%)
Bank Nifty
56,754.70 -201.30
( -0.35%)
Nifty IT
37,693.25 -683.40
( -1.78%)
Global Indices
Nasdaq
44,666.69 187.38
(0.42%)
Dow Jones
6,300.60 16.34
(0.26%)
Hang Seng
39,553.98 -92.38
(-0.23%)
Nikkei 225
8,975.66 108.64
(1.23%)
Forex
USD-INR
85.73 0.00
(0.00%)
EUR-INR
100.42 -0.13
(-0.13%)
GBP-INR
116.48 -0.10
(-0.08%)
JPY-INR
0.58 0.00
(-0.13%)

EQUITY - MARKET SCREENER

Monarch Networth Capital Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
511551
INE903D01011
97.1647152
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MONARCH
20.06
2887.41
EPS(TTM)
Face Value()
Div & Yield %
18.17
10
0.27
 

Sun Pharma updates on US FDA inspection
Jun 14,2025
Sun Pharmaceutical Industries has informed that the US FDA conducted a Good Manufacturing Practices (GMP) inspection of Sun Pharmaceutical Industries Limited's Halol facility (Gujarat, India) from 02 June to 13 June 2025. At the conclusion of the inspection, the US FDA issued a Form-483, with 8 observations.